# Kings Royal Biotech Inc. — Form D

Kings Royal Biotech Inc. of BARDWELL, KY, a company, filed a Form D exempt-offering notice with the SEC on 2018-03-30. The offering totals $29.5M, of which $750K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2018-03-30
- Form: D
- Accession: 0001735847-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $29.5M
- Amount sold: $750K
- Remaining: $28.8M
- Investors: 7
- Date of first sale: 2018-03-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-309030

## Issuer

- Name: Kings Royal Biotech Inc.
- CIK: 0001735847
- Entity type: Corporation
- Jurisdiction: KENTUCKY
- Incorporated: 2017
- Address: 2350 US HIGHWAY 51 N., BARDWELL, KY, 42023
- Phone: 9726585519

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Kenneth Gordon Kohlenberger | Director | Allen, TX |
| Robert Powell Porcella | Director | Clovis, CA |

## More

- [CIK 1735847 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1735847&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001735847-18-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.